CorAssist Cardiovascular - Innovative Solutions for heart failure with preserved ejection fraction (HFpEF)
CorAssist is pioneering the treatment of
heart failure with preserved ejection
fraction (HFpEF) patients
CorAssist Cardiovascular - Innovative Solutions for Heart Failure with Preserved Ejection Fraction (HFpEF)

Executive Staff

Yair Feld M.D., Ph.D., Cardiologist

Over 15 years of entrepreneurship and clinical research. Founder of CorAssist cardiovascular, Nephera, Paragate medical, ProArc, and GeneGrafts. B.Sc. in Physics, TAU, M.D./Ph.D. (Physiology, Biophysics), Technion, Haifa.

Yotam Resiner, Clinical Director

Dr. Reisner is a co-founder of CorAssist. Dr. Reisner has over 15 years of experience in the medical device field, leading scientific research and clinical management in various biomedical companies. Dr. Reisner holds an MD and PhD in Cardiovascular Electrophysiology from the Technion- Israel Institute of Technology.

Ruti Hoefler, Project Manager

Ruti joined CorAssist in 2016, after being R&D engineer in MicroSert. Ruti holds a BSc in Biomedical engineering from the Technion- Israel Institute of Technology.